Italy drops pharma bidding probe
Italy’s Competition Authority has ended its investigation into a temporary bidding arrangement between Kedrion and Grifols, finding the agreement did not infringe competition law even though each pharmaceutical company could have bid for the contract individually.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.